Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2017 Filed Jun 23, 2017 20:02 UTC |
Ramaswamy VivekDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001209191-17-041628 · doc4.xml · derivative · entry 1 Ramaswamy Vivek · CIK 0001635075 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:01 UTC |
KARBE FRANKDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001209191-17-041627 · doc4.xml · derivative · entry 1 KARBE FRANK · CIK 0001276700 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: Immediately exercisable. Read SEC document |
| June 21, 2017 Filed Jun 23, 2017 20:33 UTC |
MANCHESTER KEITH SDirector
|
GrantStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001209191-17-041664 · doc4.xml · derivative · entry 1 MANCHESTER KEITH S · CIK 0001244828 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2027-06-21 F1 · derivative.exercise_date: The shares underlying this option fully vested on June 21, 2017. F2 · ownership.direct: Dr. Manchester is the Head of Life Sciences and a Portfolio Manager at QVT Financial LP and serves as a director on behalf of QVT Financial LP and its affiliates. Dr. Manchester holds these stock options for the benefit of certain funds managed by QVT Financial LP. Read SEC document |
| March 24, 2017 Filed Mar 27, 2017 20:26 UTC |
BURGESS DANIEL DDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-013440 · doc1.xml · derivative · entry 1 BURGESS DANIEL D · CIK 0001239650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
| March 24, 2017 Filed Apr 5, 2017 15:40 UTC |
Howard ElizabethExec. VP & General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-014877 · doc1.xml · derivative · entry 1 Howard Elizabeth · CIK 0001669530 · Exec. VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
| March 24, 2017 Filed Apr 5, 2017 15:37 UTC |
Symonds William T.Chief Development Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-014873 · doc1.xml · derivative · entry 1 Symonds William T. · CIK 0001635078 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
| March 24, 2017 Filed Apr 5, 2017 19:44 UTC |
Sofia Michael J.Chief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-014885 · doc1.xml · derivative · entry 1 Sofia Michael J. · CIK 0001635324 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
| March 24, 2017 Filed Apr 5, 2017 19:43 UTC |
Murray Mark J.President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-014883 · doc1.xml · derivative · entry 1 Murray Mark J. · CIK 0001628383 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
| March 24, 2017 Filed Apr 5, 2017 19:39 UTC |
Cousins BruceEVP & Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-014875 · doc1.xml · derivative · entry 1 Cousins Bruce · CIK 0001628334 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
| March 24, 2017 Filed Apr 5, 2017 19:41 UTC |
Lutwyche PeterChief Technology Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001140361-17-014880 · doc1.xml · derivative · entry 1 Lutwyche Peter · CIK 0001628358 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-03-24 F1 · derivative.exercise_date: The options vest as follows: 1/3 on March 23, 2018; 1/3 on March 23, 2019; 1/3 on March 23, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.